Surgical Robots Market to Reflect Significant Incremental Opportunity During 2018-2026

The global surgical robots market is estimated to be valued at US$ 3,380.3 million in 2017 and is expected to witness a robust CAGR of 13.4% over the forecast period (2017–2025).

Surgical robots consists of a camera arm and mechanical arms with surgical instruments, which are controlled by surgeons on computer console that offers high definition and magnified 3-D view of the surgical site. Surgical robots aids in performing various complex surgical procedures with more flexibility, precision, and control than conventional surgical procedures.

Surgical robots are primarily preferred in minimally invasive surgery procedures, which are performed through tiny or small incisions. Moreover, the use of surgical robots enables surgeons to perform delicate and complex procedures, which could be difficult or impossible through other methods.

Problems associated with robotic-assisted surgery are similar to that of open surgery, which includes high risk of infection, bleeding, and cardiopulmonary risks of anesthesia. Furthermore, robotic surgery could led to death of the patient, owing to human errors in operating the technology and risks of mechanical failure. This could hamper growth of the surgical robots market.

Advancements in surgical products and technologies has led to shift from conventional surgeries to minimally invasive surgeries. The usage of robotic technology conducting minimally invasive surgeries has brought significant changes in surgical procedures. Surgical robots aid in making smaller incisions, leading to low blood, and quick recovery of patients with shorter hospital stays. In addition to this, surgical robots enhance the accuracy and precision in surgical procedures and are able to easily reach under soft tissues to operate on organs that otherwise require an open surgery. Therefore, these are ideal in minimally invasive surgeries, which is expected to be a factor driving growth of the surgical robotics market.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/496

Increase in the surgical procedures are expected to support the growth of the surgical robots market. In 2015, according to National Centre for Biotechnology Information, in the U.S., around 175,000 umbilical hernia repairs are performed each year. The share of umbilical and paraumbilical hernia repairs among all repairs for abdominal wall hernias increased from 5% to 14% in the U.K. over the last 25 years.

Furthermore, increasing regulatory approvals supports the growth of surgical robots market. For instance, MEDTECH, a company based in France received a Food and Drug Administration clearance in 2016, to introduce its ROSA Spine system for performing minimally invasive procedures on the spine, which supports the growth of surgical robots market in near future.

Advancements in technology in the surgical robotic systems is expected to augment the surgical robots market growth

North America accounts for the largest share in the global surgical robots market, followed by Europe. This is mainly attributed to high presence of robotic surgical system manufacturers in the U.S. For instance, Intuitive Surgical — a U.S.-based company — that manufactures da Vinci surgical system and is one of the leading surgical robots manufacturer.

Advancements in technology in surgical robotic systems have efficiently brought down costs of medical care by eliminating human error, reducing operating time, streamlining operating theatres, and preserving staff for other critical procedures. Surgical robots enable in better flexibility than human hands by using a joystick, which mimics surgeons hand movements with the robotic instruments. Manufacturers are focusing on upgrading their robotic instruments and accessories with features such as ability of high power computing and minute level precision with introduction of flexible and agile robots to perform minimally invasive surgery. This is expected to aid them in gaining a competitive edge in the market.

Click To Reading More On Surgical Robots Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]

Pharmacy Automation Market Benefit and Volume 2018 with Status and Prospect to 2026

Pharmacy automation is a mechanical process where handling and distribution of medications takes place in hospital pharmacy or at retail pharmacy. It includes any pharmacy task that involves counting of small objects such as tablets or capsules, measuring and mixing of powders and liquids for compounding, tracking and updating customer information in databases such as personally identifiable information (PPI), drug interaction risk detection, medical history and inventory management. The pharmacy automation market is expected to favor the growth owing to features such as system integration, which increases the productivity and time to clinicians for patient care.

Furthermore, demand for pharmaceutical products, technologically advanced robotic equipment and tools to perform operations at faster rate pharmacy automation is required in the near future. Whereas, constant developments in technology favors dispensing of prescription medications safer, more accurate and more efficient. Pharmacy automation has helped to provide improved workflow and efficiency to pharmacist as pharmacy automation can manage over 200-300 medications and patient information in an effective and secure manner. Furthermore, increasing government initiatives to improve healthcare infrastructure in emerging economies such as India and China is in turn expected to fuel growth of the pharmacy automation market.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/472

Increase in need to reduce medication errors fuels the pharmacy automation market

Medication errors such as failure in the drug prescription or dispensing process is lethal to patients, which occurs due to increase in number of customers and work load on pharmacist that encourages the pharmacist to buy pharmacy automation. Whereas pharmacy automation systems in hospital or at retail pharmacy manages, track drug, supplies health information related to patient so that replenishing of only  required items is performed. Additionally, pharmacy automation market is expected to gain traction due to its transparent tracking systems as pharmacy automation accurately maintain the record of medications expiry date and physical quantities which helps to reduce the medication error. According to National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) around 0.1 million people die annually due to medical errors in hospital in 2014.

Increase in number of drug prescriptions at pharmacies due to growth in aging population in North America and increase in insurance coverage in the U.S. has elevated the burden from healthcare system of the country, which has highlighted that there is need of improvement in management of work, which is possible by using pharmacy automation.

Furthermore, rapid rise in number of patients and demand for quality care is expected to have a positive impact and also increase in technology advancement in healthcare IT infrastructure also boost the pharmacy automation market in Latin America, Middle East, Africa and Asia Pacific.

Key players to support pharmacy automation market

Technological advancement in pharmacy automation systems have improved pharmacy operation which leads to competition in various manufactures to innovate the product. For example Becton Dickinson and Company developed Cato Mediation Workflow software with an optional camera-based visual documentation hardware that provides visual documentation of syringe, vial and IV container information. Key player operating in pharmacy automation market include Baxter International Inc., Cerner Corporation, Becton Dickinson and Company, McKesson Corporation, Swisslog Holdings AG, Capsa Healthcare, ScriptPro LLC, Yuyama Co., Ltd., Omnicell Inc. and Talyst, Inc

Click To Reading More On Pharmacy Automation Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]

Hearing Protection Devices Market Demands and Growth Prediction, Outlook 2018-2026

Hearing Protection Devices Market: Overview

Hearing loss is the inability to hear any kind of sounds, whereas deafness is the inability to know and understand speech heard even after the sound is amplified. Intense deafness means an individual cannot hear at all, characterized by the inability to detect or identify sound, even at highest volume. According to Hearing Loss Association of American, in 2013, around 20% of the population of the U.S.—approximately 48 million people—reported some level of hearing loss. At an older age of around 65 years, the proportion of hearing loss is 1:3. Around 60% of individuals who experience hearing loss are either part of the workforce or are in an educational settings. In the U.S., 2-3 in every 1,000 children are born with hearing loss, naturally, by either one or both the ears, and around 15% of teenagers have some level of hearing loss.

Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/insight/request-sample/199

A study conducted by Noise and Health organization in Accura, Ghana, a total of 101 mill workers were examined and found that 23.7% were identified with the hearing loss symptoms. According to the Bureau of Labor Statistics’ (BLS) Quarterly Census of Employment and Wages, there are of approximately 74% of hearing loss cases in the U.S. due to manufacturing. Furthermore, approximately 12 million workers in the country are involved in the manufacturing sector. Bureau of Labor Statistics’ (BLS) explains that hearing loss is one of the factor of any individual illness among the manufacturing workers. According to Survey of Occupational Injuries and Illnesses, in the U.S., in 2012, hearing loss accounted for 12% or 18, 500 cases of all recordable cases.

This report segments the global hearing protection devices market on the basis of product type, protector, end user, and geography. On the basis of product type, the market is categorized into ear plugs, earmuffs, uniform attenuation earplugs and hearing bands. On the basis of protector, the market is categorized into enclosure, aural insert, super-aural protectors and circum-aural protector. On the basis of end user, the market is categorized into construction, forestry, military, mining, manufacturing, healthcare and others.

Key features of the study:

  • This report provides in-depth analysis of the hearing protecting devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

  • It profiles leading players in the global hearing protection devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

  • The global hearing protection devices market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers for hearing protection system, research and consulting firms, new entrants, and financial analysts

  • Some of the major players involved in global hearing protection include 3M, Starkey Laboratories India Pvt. Ltd, Honeywell International Inc, Hellberg Safety Ab, Amplifon., Dynamic Ear Company, Centurion Safety Products Ltd., Sonomax Technologies Inc, Siemens Healthcare GmbH, ADCO Hearing Products Inc, and Elvex Corporation and Moldex-Metric Inc.

To know the latest trends and insights prevalent in the hearing protection devices market, click the link below: https://www.coherentmarketinsights.com/market-insight/hearing-protection-devices-market-199

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Tuberculosis Drugs Market by Region, Product and End Users Forecast to 2026

Tuberculosis Drugs Market Growth Analysis By KeyLeading Players Pfizer Inc, Lupin Laboratories Ltd, AstraZeneca Plc, Cadila Pharmaceuticals, Novartis AG, Alkem Laboratories Ltd, and Cipla Ltd

Tuberculosis Drugs Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Tuberculosis Drugs Market research report. The report has been added in his large database by Coherent Market Insights.”

Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/191

Multidrug-Resistant Tuberculosis (MDR-TB) is highly prevalent worldwide. Around 3% of all new cases diagnosed with TB worldwide have multidrug-resistant tuberculosis and the percentage is more in patients who had already accepted anti-tuberculosis treatment replicating the failure of programs intended to ensure complete cure of patients with tuberculosis. Management of multidrug-resistant tuberculosis is difficult and it requires skilled clinicians at centers with well-equipped laboratory services and DOTS-Plus strategy.

Tuberculosis Drugs Market Growth Analysis By KeyLeading Players Pfizer Inc, Lupin Laboratories Ltd, AstraZeneca Plc, Cadila Pharmaceuticals, Novartis AG, Alkem Laboratories Ltd, and Cipla Ltd

Prevalence of tuberculosis is high in low-income and emerging economies such as Asia, which includes China, India, Bangladesh, Indonesia, and Pakistan contributing 50% of the global tuberculosis burden. Africa is one of the most tuberculosis infested regions globally and unambiguously the sub-Saharan Africa has the highest rate of tuberculosis incidence, with 83 and 290 patients per 100,000, respectively. Tuberculosis cases occur highly between the age group of 15 to 49 year.

According to World Health Organization (WHO), tuberculosis accounted for burden of US$ 12 billion from low income economies. According to the same source, average work time lost by an individual after getting infected by tuberculosis bacteria is around 3–4 months, which further result in a mean lost potential earnings of 20%–30% of the annual household income and over deaths caused by premature tuberculosis deaths the loss of income is ~15 years Therefore, the global tuberculosis drugs market is expected to witness steady growth over the forecast period.

For comprehensive understanding of market dynamics, the global tuberculosis drugs market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Get Discount @ https://www.coherentmarketinsights.com/insight/request-discount/191

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Single-Use Medical Device Reprocessing Market Widespread Research and Fundamental study to 2026

Single-use medical device reprocessing is the concept of sterilizing, repackaging, testing, and manufacturing a used product. There is no clear definition for the term single-use device and it is entirely based upon the end user perception. Reprocessing of single-use device is acceptable, if the device is properly sterilized while keeping its physical and technological functionalities intact. Single-use medical device reprocessing is done in two ways: third party processing and in-hospital processing. Third party processing is considered to be a better option, as regulatory authorities are able to impose strict regulations for validation and quality assurance purpose.

Single-use medical device reprocessing is gaining popularity as it helps to reduce hospital waste and allows for major cost savings. For instance, Kaiser Permanente, which is an integrated delivery network based in U.S., saved US$ 11 million on an annual basis by reprocessing of single-use devices. Reprocessing enables the hospitals to purchase the same device at a lower price in comparison to the cost of original equipment, which eventually leads to cost savings. Practice Green Health, an NGO providing environmental solutions to the healthcare sector, quoted that single-use medical device reprocessing prevented the entry of 10,000 tons of medical waste during 1997–2007, by processing an estimated 50 million devices. Single-use medical device reprocessing market is poised to grow significantly, as hospitals realize potential cost savings and its ability to reduce environmental hazards.

Cost constraints for Hospitals and positive environmental impact will drive growth of the single-use medical device reprocessing market

Hospitals across the globe are facing cost pressures due to rise in price of original medical equipment. In the U.S., Obamacare and its associated guidelines might get repealed with the change in government. This could lead to low third-party reimbursement for hospitals, in turn influencing them to adopt cost saving initiatives such as single-use medical device reprocessing. The biggest advantage is that hospitals can reduce the cost associated with medical device to 50%, which becomes a crucial factor when dealing with expensive devices such as catheter and cardiac ablation devices. At present, 250 medical devices are already being processed with 10% of medical devices eligible for single-use medical device reprocessing. In terms of environmental protection, hospitals are able to reduce the medical waste to an estimated 50% by the use of single-use medical device reprocessing. Medical waste treatment not only puts enormous cost pressure on hospitals, but in countries such as U.S., China and Japan, it has become a full-fledged industry. For instance, Ascent, a subsidiary of Stryker Corporation, was able to eliminate 1,684 tons of medical waste from landfills during 2007, with the help of reprocessing. The market penetration for single-use medical device processing is poised to increase in small and mid-sized hospitals due to environmental sustainability and immense cost savings related to reprocessing.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/364

North America is estimated to be the growth pocket for single-use medical device reprocessing market

U.S. has the biggest healthcare system in the world with government spending an estimated 30% of annual budget on healthcare. U.S. is also home to large-sized hospitals such as Cleveland Clinic, Mount Sinai Hospital, Beth Israel Deaconess Medical Centre and Johns Hopkins Hospital. These hospitals are subject to meeting sustainability goals and contain costs at the back of recession. For instance, in 2007, 45% of U.S. hospitals entered into an agreement with third-party processing companies and this number increased to 70% in 2008 due to severe economic crisis. Single-use medical device reprocessing is subject to FDA and required third-party processing companies to maintain quality standards in accordance with the original equipment. FDA formulated stringent regulation to create standardization and avoid infections related to the reuse of single-use devices. FDA has set up a grievance mechanism for reporting of adverse events related to use of single-use device which in turn reinforces accountability.

In regions such as Asia Pacific, Europe and South America, there is a lack of regulatory standards is a restraining factor for the growth of single-use medical device reprocessing market. European Union has not mandated guidelines regarding the reprocessing. Individual countries such as Spain, England and France are not in favor of reprocessing. With respect to Asia Pacific, the reuse of single-use medical devices is prevalent with no set of regulations. In countries such as India, Japan and South Korea, there are no government regulations pertaining to single-use medical device reprocessing.

Single-use medical device reprocessing market is in nascent stage with few players dominating the market

The key players in the single-use medical device reprocessing market are Stryker Corporation, Medline ReNewal, Centurion Medical Products Corporation, Midwest Reprocessing Center, SterilMed Inc., Vanguard AG and Hygia Health Services Inc, among others. These players have successfully demonstrated the impact of single-use medical device reprocessing on cost savings and environmental protection. These companies will benefit in a large manner as the regulatory scenario becomes established in Europe and Asia Pacific.

Click To Reading More On Single-Use Medical Device Reprocessing Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]

Blood Flow Measurement Devices Market Industry Report by States Report Forecast to 2026

Blood Flow Measurement Devices Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Blood Flow Measurement Devices Market research report. The major takeaways in the report are product segment analysis, application segment analysis, regional segment analysis and data of the major Blood Flow Measurement Devices Market players from around the world. The report presents an introductory as well as detailed information about the Blood Flow Measurement Devices Market through a well-organized layout divided into easy to understand chapters.

CMI analyses the Blood Flow Measurement Devices trends, by country, for a five year review period (2018-2026)forecast period. Our regular clients asked us to produce detailed market segmentation, and this is what you will find here: a report without any unnecessary padding, giving a unique analysis of the sector.

Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/183

Blood flow measurement devices in healthcare sector holds an important part under diagnostic and research segment. These measurement devices help the physician to understand the nature of the blood flow such as the amount of blood supplied to the various vital organs and abnormal changes in the blood flow velocity, which can cause malformation of vessels.

Key players operating in the blood flow measurement devices market include Medtronics, Biomedix Inc, AKW Medicals Inc, Moor Instruments, Deltex Medical Ltd, D E Hokanson Inc, Cook Medical, Arjohuntleigh, Elcat GmBH, Flowtronics Inc, Ace Medicals, Carolina Medical Plc and Compumedics Ltd.

An instant, reliable, and noninvasive technique for blood flow measurement would allow for early diagnosis and effective treatment of the disease. Increasing incidence of chronic diseases and rising demand for effective and early diagnosis of such disease would fuel growth of the blood flow measurement devices market in the near future. Among all the segments, the measurement through ultrasonic Doppler technique holds the maximum revenue share in the market and this is expected to expand with significant growth rate over the forecast period. The wide range of applications such as peripheral vascular disorders, intra cranial pressure monitoring, and monitoring of various malignant and non-malignant tumors is projected to support the growth of the market in the near future.

The global market of blood flow measurement devices is consolidated, with some major players holding up the maximum share due to their efficient R&D activities. Players in the market are developing novel products through major spending on R&D to capitalize on highly lucrative opportunities in the blood flow measurement devices industry. For instance, Medtronic Plc is considered to be the toughest competitor in the market. This is mainly attributed to its extensive product portfolio and large investment in research of blood flow measuring devices.

Read Full Report with TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/183

Furthermore, new launches and FDA approval are favoring growth in their market share. For instance, in 2015, according to VertMarkets, Inc, company’s pipeline flex embolization device received FDA approval, which in turn is expected to enhance its market share in blood measurement devices market over the forecast period.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Cancer Biomarkers Market Size & Share to See Modest Growth Through 2026

Growing prevalence and incidence of various types of cancer coupled with increasing need for early diagnosis of cancers are the major factors driving growth of global Cancer Biomarkers market over the forecast period. Continuous research and development and technology advancements in cancer biomarkers had led to introduction of better and affordable biomarkers in the field of clinical diagnosis. For instance, according to the data published in Cell Metabolism Journal, in March 2018, a team of Australian researchers found a unique metabolic marker, which can detect adenocarcinomas, a form of lung cancer. These metabolic biomarkers respond to immunotherapies and offers simple, non-invasive blood test for early detection of lung cancer.

Get Free Sample Copy of This Business Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/175

In February 2018, researchers at Georgetown-Lombardi Comprehensive Cancer Center, identified biomarkers, which can use liquid biopsies to predict response to cancer treatment and help in identifying increasingly specific subsets of GI cancers to make treatment decisions. According to the data published in the European Journal of Breast Health, in October 2017, body fluid tests can be used for early detection of new or recurrent breast cancer. This new approach includes tissue testing and body fluid analysis of individuals diagnosed with breast cancer, for more effective cancer treatment.

Moreover, manufacturers are focusing on developing new cancer biomarkers, which would aid in early diagnosis of cancers and are used for oncology research studies. For instance, in November 2016, Oxford Cancer Biomarkers Ltd. introduced ColoTox test for predicting risk of toxicity with cancer chemotherapy tests. In December 2015, Olink Bioscience introduced Proseek Multiplex Oncology II96x96: 92 human protein biomarker panel for oncology research.

The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. For instance, according to the Cancer Atlas: 2017, there were an estimated 14.1 million new cancer cases in 2012. Moreover, India, China and other East and Central Asian countries accounted for nearly half of world’s new cancer cases and deaths, in 2017. Furthermore, according to the same source, by 2025, there will be an estimated 19.3 million new cancer cases and 11.4 million cancer deaths, in emerging economies. However, high cancer treatment cost and unfavorable reimbursement policies for cancer biomarker may hinder the growth of cancer biomarkers market.

Detailed Segmentation: Global Cancer Biomarkers Market, By Biomarker Type, Protein, Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers,. Global Cancer Biomarkers Market, By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, Other Cancers, Global Cancer Biomarkers Market, By End User: Hospitals, Academic and Cancer, Research Institutes, Ambulatory Surgical Centers, Cancer Diagnostic Laboratories,.

Download Free PDF Brochure of This Business Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/175

Key players operating in the cancer biomarkers market include BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Erectile Dysfunction Market Share and Analysis 2026

The global erectile dysfunction market was valued at US$ 4,129.5 million in 2015 and is expected to witness a CAGR of 0.2% during the forecast period (2016 – 2024).

Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase  with a ratio of about 5% at the age of 50 to 15% at 70 years. Even though this is a common condition, related to both age and secondary medical conditions like diabetes, hypertension, dyslipedemia, depression and cardiovascular disease, there were treatments conducted in the past by mostly andrologists, urologists and sex therapists. There has been a revolutionary introduction of oral drug therapy to treat erectile dysfunction and the enormous studies concerning erectile dysfunction has led to a paradigm shift in erectile dysfunction treatment.

According to study conducted by Canadian Institute of Health Research, there were about 4,000 Canadian men between the age 40 and 88 years, nearly half of them had erectile dysfunction. It was about approximately two times more usual in men with cardiovascular disease and four times more usual among men suffering with any kind of diabetes. Increase in the number of erectile dysfunction cases has led to an increase in the Cialis drugs, proportionally boost the erectile dysfunction market.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/200

With the significant increase in revenue of Erectile Dysfunction Market, over last decade, more than 31 chemical moiety have advanced into the therapeutic pipeline, out of which 90% of drugs/molecules are developed by companies and 10% of the molecules/drugs are developed by Medical Universities and Institutes. However, the increase in the molecules and drug in clinical trials, the global drug pipeline for erectile dysfunction is still insufficient to address the unmet needs of treatment in low income countries. One of the basic challenge for the mid-level pharmaceutical companies are their lack of regional presence across the globe. The global pharmaceutical companies are now involved in expansion of their erectile dysfunction product portfolio by merger and acquisition policies. For instance, in 2014, Endo Pharmaceutical Holdings Sale of American Medical Systems. In brief, some of the private equity firms are interested to buy American Medical Systems which is one of the leading manufacturer of products used to treat pelvic disorders of male and female, erectile dysfunction prostheses, and laser technology devices.

50 open clinical studies presently, to treat erectile dysfunction to boost the erectile dysfunction market

According to pharma industry news, in 2012, Viagra drugs dominated the erectile dysfunction market with an approximate market share of about 45% in terms of revenue. Though, the market value for Viagra has declined due to its patent expiry in European countries by 2013, however the other pharmaceutical companies has then shown a keen interest in developing the generic Viagra drug for erectile dysfunction treatment. In-spite the patent loss, US market maintained a continual growth and is expected to dominate the erectile dysfunction market by 2020. The other prominent drug after Viagra is Cialis which holds the second largest market share globally. At present the market for Cialis drug is growing exceptionally well, however there can be an expected decline of Cialis’s drug market share as the patent expiration is due in mid of 2017. Furthermore, one of the Bayer’s erectile dysfunction drug, Levitra/Staxyn is expected to lose its patent by 2018 and is thus expected to contribute to the declining market revenue for Erectile Dysfunction Market. However, as there about 50 drug molecules under clinical trials, among which few drugs are expected to launch by 2018 and 2019 owing to increase in Erectile Dysfunction Market proportionally.

Click To Reading More On Erectile Dysfunction Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]

Ablation Devices Market Rapid growth and development in pharma & biotech industries

Ablation refers to the removal of certain biological substances from internal parts of the body with the help of ablation devices. Ablation is performed through various techniques such as vaporization, laser, thermal treatments, cryo-treatments, and radiation procedures, among others. In medical sector, ablation is performed usually through surgical methods for the removal of biological substances i.e., usually a small tumor. Other techniques adopted for the removal of infected biological tissues include chemical ablation and radiofrequency ablation.

Ablation gains immense popularity all over the world, as it offers minimally invasive solutions for the removal of tissues or tumors with bearable pain and less recovery period than that of open surgical procedures. Demand for ablation devices is expected to increase owing to increasing incidence of chronic diseases, mainly tumorigenic cancer and other cardiovascular disorders, across the globe. Chronic diseases are major causes of mortality, which resulted in over 38 million deaths worldwide in 2015 according to the World Health Organization (WHO). Moreover, WHO states that cancer is one of the leading causes of death that accounts for up to 8.8 million deaths in 2015. According to Centers of Disease Control and Prevention (CDC), in 2016, an estimated 2.7-6.1 million people in the U.S. suffered from atrial fibrillation. Moreover, the same fact sheet states that around 2% of people younger than the age of 65 years are affected with atrial fibrillation. High prevalence of such diseases will in turn, boost the growth of global ablation devices market.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/464
Factors such as increasing incidence of cardiovascular disorders, rising geriatric population, spreading awareness of the benefits of ablation devices, and rapid technological advances in healthcare sector are propelling growth of the ablation devices market. Cardiovascular disorders such as, atrial fibrillation and arrhythmia, which are highly susceptible to open heart surgeries and can be treated with ablation at earlier stages. North America is the leading region of ablation devices market in terms of sales of ablation devices. The major factors affecting growth of ablation devices market in North America include well-established healthcare infrastructure and substantial expenditure targeted on developing the healthcare facilities. Furthermore, rising demand for minimally invasive surgical procedures, especially in the treatment of cardiac arrhythmia, is also expected to propel the market growth

However, major factors hindering the growth of ablation devices market are costly treatment of ablation surgery and major side effects of surgical ablation procedures such as chemical allergies and strokes.

Key players involved in the strategic implementation of various policies for technological advancements and innovation of ablation devices are,

In 2016, Medtronic expanded its pain therapies portfolio with the launch of OsteoCool RF ablation system. The company expanded its minimally invasive therapy portfolio with the acquisition of the gynecology business from Smith & Nephew.

In 2015, EDAP TMS announced a multinational strategic OEM partnership with Quanta System, which is a leading manufacturer of medical lasers for surgical applications. Through this partnership, Quanta manufactures customized urological stone lasers to be sold under EDAP brand.

In 2015, AtricCure, Inc. acquired nContact, Inc., a privately-held developer of innovative cardiac ablation solutions to provide improved market access to ablation devices.

In 2016, Boston Scientific Corporation acquired Cosman Medical to get its hands on the company’s Radiofrequency Ablation (RFA) system, in order to expand its neuromodulation portfolio.

Click To Reading More On Ablation Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]

Shock Wave Therapy Devices Market Granular View Of The From Various End-Use Segments

Shock wave therapy also called extracorporeal shock wave therapy (ESWT) is a non-invasive treatment that is used in wide areas of medical field that includes physical therapy, orthopedics, cardiology, and urology. Shock wave therapy is an alternative treatment for orthopedic surgeries. The term extracorporeal signifies the external shock generation, and the resultant shock waves are then transmitted to the internal parts of the body via intermediate pads through the skin. Shock wave therapy is undertaken mainly by patients suffering from tendons and joints disorders. This therapy is known to perform very efficient mobility restoration and pain management. The shock wave therapy is carried out with the help of specialized devices called shock wave therapy devices. These devices intend to treat several indications that leads to chronic and acute pain and as well as helps to speed up the process of recovery within patients suffering from chronic and sub-chronic conditions of painful bones, spots, myoskeletal tissues and soft tissues. The shock wave therapy provides faster healing, revascularization and regeneration of the bones, ligaments and tendons.

Rise in prevalence of arthritis and musculoskeletal disorders to fuel growth of shock wave therapy devices market

According to Health and Safety Executive, the UK, 41% of ill health was encountered among the UK employees due to work related musculoskeletal disorders (WRMSD), accounting for around 1,311,000 cases in 2014. Furthermore, according to the Center for Disease Control (CDC) around 22.7% of adults are reported with some or the other kind of arthritis, accounting for 54.4 million cases during 2013-2015. The high prevalence rate of musculoskeletal disorders creates a highly conducive environment for growth of shock wave therapy devices market.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/456

On the basis of geographical region, the global shock wave therapy market is segmented as North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America accounts for the largest share in the global market, owing to technological advancements and major investments in R&D of medical device technology. The Asia Pacific region is expected to come up with fast growing market owing to increasing population, changing lifestyle and development in healthcare infrastructure. According to a report by Population Reference Bureau, global population is projected to increase 33% from 2016 estimates to reach 9.9 billion by 2050. This population is expected to be characterized by a significantly large geriatric population. This demographic group is highly susceptible to injuries, which in turn creates a highly positive growth environment for the global shock wave therapy devices market in the near future.

The demand for non-invasive and hassle-free techniques responsible for driving the global shock wave therapy market

The demand for technologically advanced treatment for pain management and non- invasive nature of this therapy is the prime factor that is responsible to drive the global shock therapy market. The ability of shock waves therapy devices to increase cellular activity of the body and metabolic stimulation is also responsible to attract a large population. Furthermore, increase in the rate of prevalence of bone diseases as well increasing geriatric population are also playing a pivotal role to boost the global shock wave therapy devices market. However, the high cost of the therapy and lack of skillful workers to operate these devices could hinder the market growth up to some extent.

Click To Reading More On Shock Wave Therapy Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]